Show simple item record

A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B

dc.contributor.authorPasi, KJen_US
dc.contributor.authorGeorgiev, Pen_US
dc.contributor.authorMant, Ten_US
dc.contributor.authorCreagh, MDen_US
dc.contributor.authorLissitchkov, Ten_US
dc.contributor.authorBevan, Den_US
dc.contributor.authorAustin, Sen_US
dc.contributor.authorHay, CRen_US
dc.contributor.authorBrand, Ben_US
dc.contributor.authorKazmi, Ren_US
dc.contributor.authorChowdary, Pen_US
dc.contributor.authorRagni, MVen_US
dc.contributor.authorChen, Jen_US
dc.contributor.authorAkinc, Aen_US
dc.contributor.authorSorensen, Ben_US
dc.contributor.authorRangarajan, Sen_US
dc.date.accessioned2016-09-20T13:12:14Z
dc.date.issued2016-07en_US
dc.date.submitted2016-08-22T16:44:57.786Z
dc.identifier.issn1351-8216en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/15464
dc.descriptionAbstract from WFH 2016 World Congress Abstracts, Orlando, Florida, USA, July 24–28, 2016en_US
dc.format.extent76 - 76en_US
dc.relation.ispartofHAEMOPHILIAen_US
dc.titleA Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or Ben_US
dc.typeArticle
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000379940900264&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume22en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record